{"id":7880,"date":"2024-12-11T16:12:29","date_gmt":"2024-12-11T08:12:29","guid":{"rendered":"https:\/\/regask.com\/?p=7880"},"modified":"2024-12-11T16:12:29","modified_gmt":"2024-12-11T08:12:29","slug":"directrices-de-farmacia-de-insumos-de-agemed-en-bolivia","status":"publish","type":"post","link":"https:\/\/regask.com\/es\/bolivia-agemed-input-pharmacy-guidelines\/","title":{"rendered":"AGEMED (Bolivia) abre consulta p\u00fablica sobre borrador de gu\u00eda\u2026"},"content":{"rendered":"<div class=\"flex max-w-full flex-col flex-grow\">\n<div class=\"min-h-8 text-message flex w-full flex-col items-end gap-2 whitespace-normal break-words [.text-message+&amp;]:mt-5\" dir=\"auto\" data-message-author-role=\"assistant\" data-message-id=\"21bd5e6d-5314-4f16-82c8-f869c4c0d348\" data-message-model-slug=\"gpt-4o\">\n<div class=\"flex w-full flex-col gap-1 empty:hidden first:pt-[3px]\">\n<div class=\"markdown prose w-full break-words dark:prose-invert light\">\n<p>The <a href=\"https:\/\/regask.com\/bolivia-senate-filed-a-bill-on-fop-labeling\/\">Bolivian Agency<\/a> for Medicines and Health Technologies (AGEMED) announced on November 25, 2024, the launch of a public consultation on its proposed guidelines titled &#8220;Good Pharmacy Practices for Compounding Pharmacies.&#8221; This initiative seeks to establish comprehensive standards to ensure the quality and safety of compounded medications.<\/p>\n<p>The draft guidelines are designed to regulate operational procedures in compounding pharmacies, with a focus on quality control, storage, and prescription handling. The objective is to safeguard patient safety and ensure the efficacy of personalized medications created to meet specific patient needs that are not addressed by commercially available products.<\/p>\n<p>Key areas of focus include stringent hygiene practices, accurate record-keeping, and adherence to prescribed formulations to minimize contamination risks and ensure dosing accuracy. While the guidelines do not specify particular product categories or therapeutic areas, they are expected to have broad applicability across various compounded medications, including dermatological and pediatric formulations.<\/p>\n<p>This initiative represents a significant step in enhancing the regulatory framework governing compounding pharmacies in Bolivia, aiming to align practices with international standards and improve patient outcomes through better oversight.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"mb-2 flex gap-3 empty:hidden -ml-2\">\n<div class=\"items-center justify-start rounded-xl p-1 flex\">\n<div class=\"flex items-center\">\u00a0<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>La Agencia Boliviana de Medicamentos y Tecnolog\u00edas Sanitarias (AGEMED) anunci\u00f3 el 25 de noviembre de 2024 el inicio de una consulta p\u00fablica sobre sus directrices propuestas, tituladas \u201cBuenas Pr\u00e1cticas Farmac\u00e9uticas para Farmacias de Preparaci\u00f3n Magistral\u201d. Esta iniciativa busca establecer est\u00e1ndares integrales para garantizar la calidad y seguridad de los medicamentos preparados magistralmente. El borrador de las directrices est\u00e1 dise\u00f1ado para regular las operaciones\u2026<\/p>","protected":false},"author":43,"featured_media":7904,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[35],"tags":[606],"class_list":["post-7880","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharma-biotech-latest-insights","tag-compounding-pharmacies-regs"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.4 (Yoast SEO v28.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Bolivia AGEMED Seeks Input on Pharmacy Rules | RegASK<\/title>\n<meta name=\"description\" content=\"Bolivia\u2019s AGEMED opens public consultation on draft guidelines for compounding pharmacies, focusing on quality &amp; safety. Read more at RegASK.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/es\/directrices-de-farmacia-de-insumos-de-agemed-en-bolivia\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AGEMED (Bolivia) Opens Public Consultation on Draft Guidelines for Compounding Pharmacies\" \/>\n<meta property=\"og:description\" content=\"Bolivia\u2019s AGEMED opens public consultation on draft guidelines for compounding pharmacies, focusing on quality &amp; safety. Read more at RegASK.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/es\/directrices-de-farmacia-de-insumos-de-agemed-en-bolivia\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-11T08:12:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/12\/agemed-bolivia-opens-public-consultation-on-draft-guidelines-for-compounding-pharmacies.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Reva Ananda\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Reva Ananda\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/bolivia-agemed-input-pharmacy-guidelines\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/bolivia-agemed-input-pharmacy-guidelines\\\/\"},\"author\":{\"name\":\"Reva Ananda\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/4023a3aab44f61a84d06ca8abfcbe926\"},\"headline\":\"AGEMED (Bolivia) Opens Public Consultation on Draft Gui&hellip;\",\"datePublished\":\"2024-12-11T08:12:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/bolivia-agemed-input-pharmacy-guidelines\\\/\"},\"wordCount\":187,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/bolivia-agemed-input-pharmacy-guidelines\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/agemed-bolivia-opens-public-consultation-on-draft-guidelines-for-compounding-pharmacies.png\",\"keywords\":[\"Compounding Pharmacies Regs\"],\"articleSection\":[\"Pharma and Biotech\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/bolivia-agemed-input-pharmacy-guidelines\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/bolivia-agemed-input-pharmacy-guidelines\\\/\",\"name\":\"Bolivia AGEMED Seeks Input on Pharmacy Rules | RegASK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/bolivia-agemed-input-pharmacy-guidelines\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/bolivia-agemed-input-pharmacy-guidelines\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/agemed-bolivia-opens-public-consultation-on-draft-guidelines-for-compounding-pharmacies.png\",\"datePublished\":\"2024-12-11T08:12:29+00:00\",\"description\":\"Bolivia\u2019s AGEMED opens public consultation on draft guidelines for compounding pharmacies, focusing on quality & safety. Read more at RegASK.\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/bolivia-agemed-input-pharmacy-guidelines\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/regask.com\\\/bolivia-agemed-input-pharmacy-guidelines\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/agemed-bolivia-opens-public-consultation-on-draft-guidelines-for-compounding-pharmacies.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/agemed-bolivia-opens-public-consultation-on-draft-guidelines-for-compounding-pharmacies.png\",\"width\":800,\"height\":600,\"caption\":\"Agemed Bolivia Opens Public Consultation On Draft Guidelines For Compounding Pharmacies\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\",\"name\":\"RegASK\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"width\":401,\"height\":401,\"caption\":\"RegASK\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RegASKRegulatoryAffairs\\\/\",\"https:\\\/\\\/x.com\\\/ASKRegASK\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/RegASK\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@RegASK\",\"https:\\\/\\\/www.crunchbase.com\\\/organization\\\/regask\",\"https:\\\/\\\/www.bloomberg.com\\\/profile\\\/company\\\/1691237D:SP\",\"https:\\\/\\\/pitchbook.com\\\/profiles\\\/company\\\/265004-02\",\"https:\\\/\\\/www.cbinsights.com\\\/company\\\/RegASK\",\"https:\\\/\\\/vimeo.com\\\/RegASK\"],\"legalName\":\"RegASK PTE. LTD.\",\"foundingDate\":\"2018\",\"slogan\":\"Empowering Smarter Regulatory Decisions\",\"description\":\"Agentic AI regulatory intelligence and workflow orchestration platform for Life Sciences and Consumer Products. RegASK combines vertical LLMs, multi-agent AI architecture, and a global community of 1,800+ subject matter experts to deliver regulatory horizon scanning, impact analysis, compliance workflow automation, and audit-ready outputs across 160+ countries.\",\"areaServed\":\"Worldwide\",\"founder\":{\"@type\":\"Person\",\"name\":\"Caroline Shleifer\",\"jobTitle\":\"Founder & CEO\"},\"address\":{\"@type\":\"PostalAddress\",\"streetAddress\":\"79 Science Park Drive, #06-01, Cintech IV\",\"addressLocality\":\"Singapore\",\"postalCode\":\"118264\",\"addressCountry\":\"SG\"},\"contactPoint\":{\"@type\":\"ContactPoint\",\"telephone\":\"+65 6817 6290\",\"contactType\":\"customer service\",\"availableLanguage\":[\"English\",\"French\",\"Japanese\",\"Spanish\",\"Chinese\",\"German\"]},\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":50,\"maxValue\":100},\"knowsAbout\":[\"Regulatory Intelligence\",\"Regulatory Compliance\",\"Regulatory Affairs\",\"Workflow Orchestration\",\"Life Sciences Regulation\",\"Consumer Products Regulation\",\"AI-Driven Compliance\"],\"hasCertification\":[{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 42001:2023\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27001:2022\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27701\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27018:2019\"},{\"@type\":\"Certification\",\"name\":\"SOC 2 Type II\"}]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/4023a3aab44f61a84d06ca8abfcbe926\",\"name\":\"Reva Ananda\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"AGEMED Bolivia solicita aportes sobre normativa farmac\u00e9utica | RegASK","description":"La AGEMED de Bolivia abre consulta p\u00fablica sobre el borrador de directrices para farmacias de f\u00f3rmulas magistrales, con \u00e9nfasis en la calidad y la seguridad. Lea m\u00e1s en RegASK.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/es\/directrices-de-farmacia-de-insumos-de-agemed-en-bolivia\/","og_locale":"es_ES","og_type":"article","og_title":"AGEMED (Bolivia) Opens Public Consultation on Draft Guidelines for Compounding Pharmacies","og_description":"Bolivia\u2019s AGEMED opens public consultation on draft guidelines for compounding pharmacies, focusing on quality & safety. Read more at RegASK.","og_url":"https:\/\/regask.com\/es\/directrices-de-farmacia-de-insumos-de-agemed-en-bolivia\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2024-12-11T08:12:29+00:00","og_image":[{"width":800,"height":600,"url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/12\/agemed-bolivia-opens-public-consultation-on-draft-guidelines-for-compounding-pharmacies.png","type":"image\/png"}],"author":"Reva Ananda","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Reva Ananda","Est. reading time":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/bolivia-agemed-input-pharmacy-guidelines\/#article","isPartOf":{"@id":"https:\/\/regask.com\/bolivia-agemed-input-pharmacy-guidelines\/"},"author":{"name":"Reva Ananda","@id":"https:\/\/regask.com\/#\/schema\/person\/4023a3aab44f61a84d06ca8abfcbe926"},"headline":"AGEMED (Bolivia) Opens Public Consultation on Draft Gui&hellip;","datePublished":"2024-12-11T08:12:29+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/bolivia-agemed-input-pharmacy-guidelines\/"},"wordCount":187,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/bolivia-agemed-input-pharmacy-guidelines\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/12\/agemed-bolivia-opens-public-consultation-on-draft-guidelines-for-compounding-pharmacies.png","keywords":["Compounding Pharmacies Regs"],"articleSection":["Pharma and Biotech"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/regask.com\/bolivia-agemed-input-pharmacy-guidelines\/","url":"https:\/\/regask.com\/bolivia-agemed-input-pharmacy-guidelines\/","name":"AGEMED Bolivia solicita aportes sobre normativa farmac\u00e9utica | RegASK","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/bolivia-agemed-input-pharmacy-guidelines\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/bolivia-agemed-input-pharmacy-guidelines\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/12\/agemed-bolivia-opens-public-consultation-on-draft-guidelines-for-compounding-pharmacies.png","datePublished":"2024-12-11T08:12:29+00:00","description":"La AGEMED de Bolivia abre consulta p\u00fablica sobre el borrador de directrices para farmacias de f\u00f3rmulas magistrales, con \u00e9nfasis en la calidad y la seguridad. Lea m\u00e1s en RegASK.","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/bolivia-agemed-input-pharmacy-guidelines\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/regask.com\/bolivia-agemed-input-pharmacy-guidelines\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/12\/agemed-bolivia-opens-public-consultation-on-draft-guidelines-for-compounding-pharmacies.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/12\/agemed-bolivia-opens-public-consultation-on-draft-guidelines-for-compounding-pharmacies.png","width":800,"height":600,"caption":"Agemed Bolivia Opens Public Consultation On Draft Guidelines For Compounding Pharmacies"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"El sistema operativo de IA regulatoria para equipos de alto rendimiento","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/regask.com\/#organization","name":"RegASK","url":"https:\/\/regask.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","width":401,"height":401,"caption":"RegASK"},"image":{"@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","https:\/\/x.com\/ASKRegASK","https:\/\/www.linkedin.com\/company\/RegASK\/","https:\/\/www.youtube.com\/@RegASK","https:\/\/www.crunchbase.com\/organization\/regask","https:\/\/www.bloomberg.com\/profile\/company\/1691237D:SP","https:\/\/pitchbook.com\/profiles\/company\/265004-02","https:\/\/www.cbinsights.com\/company\/RegASK","https:\/\/vimeo.com\/RegASK"],"legalName":"RegASK PTE. LTD.","foundingDate":"2018","slogan":"Empowering Smarter Regulatory Decisions","description":"Plataforma de inteligencia regulatoria y orquestaci\u00f3n de flujos de trabajo con IA para ciencias de la vida y productos de consumo. RegASK combina modelos de negocio verticales, arquitectura de IA multiagente y una comunidad global de m\u00e1s de 1800 expertos para ofrecer an\u00e1lisis de horizontes regulatorios, an\u00e1lisis de impacto, automatizaci\u00f3n de flujos de trabajo de cumplimiento y resultados listos para auditor\u00edas en m\u00e1s de 160 pa\u00edses.","areaServed":"Worldwide","founder":{"@type":"Person","name":"Caroline Shleifer","jobTitle":"Founder & CEO"},"address":{"@type":"PostalAddress","streetAddress":"79 Science Park Drive, #06-01, Cintech IV","addressLocality":"Singapore","postalCode":"118264","addressCountry":"SG"},"contactPoint":{"@type":"ContactPoint","telephone":"+65 6817 6290","contactType":"customer service","availableLanguage":["English","French","Japanese","Spanish","Chinese","German"]},"numberOfEmployees":{"@type":"QuantitativeValue","minValue":50,"maxValue":100},"knowsAbout":["Regulatory Intelligence","Regulatory Compliance","Regulatory Affairs","Workflow Orchestration","Life Sciences Regulation","Consumer Products Regulation","AI-Driven Compliance"],"hasCertification":[{"@type":"Certification","name":"ISO\/IEC 42001:2023"},{"@type":"Certification","name":"ISO\/IEC 27001:2022"},{"@type":"Certification","name":"ISO\/IEC 27701"},{"@type":"Certification","name":"ISO\/IEC 27018:2019"},{"@type":"Certification","name":"SOC 2 Type II"}]},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/4023a3aab44f61a84d06ca8abfcbe926","name":"Reva Ananda"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/7880","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/users\/43"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/comments?post=7880"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/7880\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media\/7904"}],"wp:attachment":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media?parent=7880"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/categories?post=7880"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/tags?post=7880"}],"curies":[{"name":"Gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}